| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Anthracyclines for gestational breast cancer: course and outcome of pregnancy
|
Azim Jr, H.A.
|
|
|
19 |
8 |
p. 1511-1512
|
article
|
| 2 |
A phase II multicenter study of oxaliplatin in combination with paclitaxel in poor prognosis patients who failed cisplatin-based chemotherapy for germ-cell tumors
|
Theodore, C.
|
|
|
19 |
8 |
p. 1465-1469
|
article
|
| 3 |
Arsenic trioxide down-regulates antiapoptotic genes and induces cell death in mycosis fungoides tumors in a mouse model
|
Tun-Kyi, A.
|
|
|
19 |
8 |
p. 1488-1494
|
article
|
| 4 |
Association between CYP2D6 *10 genotype and survival of breast cancer patients receiving tamoxifen treatment
|
Xu, Y.
|
|
|
19 |
8 |
p. 1423-1429
|
article
|
| 5 |
Cetuximab in combination with weekly 5-fluorouracil/folinic acid and oxaliplatin (FUFOX) in untreated patients with advanced colorectal cancer: a phase Ib/II study of the AIO GI Group
|
Arnold, D.
|
|
|
19 |
8 |
p. 1442-1449
|
article
|
| 6 |
Clinical heterogeneity of extranodal NK/T-cell lymphoma, nasal type: a national survey of the Korean Cancer Study Group
|
Kim, T.M.
|
|
|
19 |
8 |
p. 1477-1484
|
article
|
| 7 |
Clinical impact of the methotrexate resistance-associated genes C-MYC and dihydrofolate reductase (DHFR) in high-grade osteosarcoma
|
Scionti, I.
|
|
|
19 |
8 |
p. 1500-1508
|
article
|
| 8 |
Cologne high-dose sequential chemotherapy in relapsed and refractory Hodgkin lymphoma: results of a large multicenter study of the German Hodgkin Lymphoma Study Group (GHSG)
|
|
|
|
19 |
8 |
p. 1515
|
article
|
| 9 |
Creating a stronger front against cancer: ESMO and ECCO join forces
|
Baselga, José
|
|
|
19 |
8 |
p. 1367-1368
|
article
|
| 10 |
Does oxaliplatin and paclitaxel combination show an activity of some extent in pretreated patients with germ-cell tumors?
|
Necchi, A.
|
|
|
19 |
8 |
p. 1509
|
article
|
| 11 |
Editorial Board
|
|
|
|
19 |
8 |
p. ii-iii
|
article
|
| 12 |
Effects of an endurance and resistance exercise program on persistent cancer-related fatigue after treatment
|
Dimeo, F.
|
|
|
19 |
8 |
p. 1495-1499
|
article
|
| 13 |
Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer
|
Gruber, G.
|
|
|
19 |
8 |
p. 1393-1401
|
article
|
| 14 |
First-line bevacizumab combined with reduced dose interferon-α2a is active in patients with metastatic renal cell carcinoma
|
Melichar, B.
|
|
|
19 |
8 |
p. 1470-1476
|
article
|
| 15 |
Infusion of trastuzumab maintenance doses over 30 minutes
|
Ring, A.
|
|
|
19 |
8 |
p. 1509-1510
|
article
|
| 16 |
In this issue
|
|
|
|
19 |
8 |
p. 1365
|
article
|
| 17 |
Large bowel perforation associated with capecitabine treatment for breast cancer
|
Cowman, S.
|
|
|
19 |
8 |
p. 1510-1511
|
article
|
| 18 |
Modulation of ER phosphorylation on serine 118 by endocrine therapy: a new surrogate marker for efficacy
|
Zoubir, M.
|
|
|
19 |
8 |
p. 1402-1406
|
article
|
| 19 |
Neutrophil role in in vivo anti-lymphoma activity of rituximab: FCGR3B-NA1/NA2 polymorphism does not influence response and survival after rituximab treatment
|
Cartron, G.
|
|
|
19 |
8 |
p. 1485-1487
|
article
|
| 20 |
Phase II study of sequentially administered low-dose mitomycin-C (MMC) and irinotecan (CPT-11) in women with metastatic breast cancer (MBC)
|
Mrozek, E.
|
|
|
19 |
8 |
p. 1417-1422
|
article
|
| 21 |
Practical guidance for the management of aromatase inhibitor-associated bone loss
|
Hadji, P.
|
|
|
19 |
8 |
p. 1407-1416
|
article
|
| 22 |
Quality of life and comorbidity score as prognostic determinants in non-small-cell lung cancer patients
|
Jacot, W.
|
|
|
19 |
8 |
p. 1458-1464
|
article
|
| 23 |
Randomized phase III study comparing irinotecan combined with 5-fluorouracil and folinic acid to cisplatin combined with 5-fluorouracil in chemotherapy naive patients with advanced adenocarcinoma of the stomach or esophagogastric junction
|
Dank, M.
|
|
|
19 |
8 |
p. 1450-1457
|
article
|
| 24 |
Satisfaction with and psychological impact of immediate and deferred breast reconstruction
|
Fernández-Delgado, J.
|
|
|
19 |
8 |
p. 1430-1434
|
article
|
| 25 |
Stopping a trial early in oncology: for patients or for industry?
|
Whitehead, J.
|
|
|
19 |
8 |
p. 1512-1513
|
article
|
| 26 |
Survival and reproductive function of 52 women treated with surgery and bleomycin, etoposide, cisplatin (BEP) chemotherapy for ovarian yolk sac tumor
|
de La Motte Rouge, T.
|
|
|
19 |
8 |
p. 1435-1441
|
article
|
| 27 |
Table of Contents
|
|
|
|
19 |
8 |
p. iv-v
|
article
|
| 28 |
Targeting Src in breast cancer
|
Finn, R.S.
|
|
|
19 |
8 |
p. 1379-1386
|
article
|
| 29 |
Temsirolimus in metastatic renal cell carcinoma
|
Négrier, S.
|
|
|
19 |
8 |
p. 1369-1370
|
article
|
| 30 |
Temsirolimus safety profile and management of toxic effects in patients with advanced renal cell carcinoma and poor prognostic features
|
Bellmunt, J.
|
|
|
19 |
8 |
p. 1387-1392
|
article
|
| 31 |
UFT (tegafur–uracil) in rectal cancer
|
Casado, E.
|
|
|
19 |
8 |
p. 1371-1378
|
article
|
| 32 |
Value of frontline autologous stem-cell transplantation in peripheral T-cell lymphoma
|
Gutierrez, A.
|
|
|
19 |
8 |
p. 1512
|
article
|
Journal description